TP53 was suggested as a potential candidate susceptibility gene for ovarian cancer from a case only study [34] and from a whole-exome sequencing analysis where protein truncating variants were identified at a greater frequency in ovarian cancer cases compared to publicly available controls (OR 18.5; 95% CI, 2.6–808.1) [34,57]. The gene discussed is TP53; the disease is ovarian cancer.